Mindmed to host conference call and webcast to discuss 2023 financial results and provide business update

New york--(business wire)---- $mnmd--mind medicine (mindmed) inc. (nasdaq: mnmd) (cboe canada: mmed) (the “company” or “mindmed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on wednesday, february 28, 2024, at 8:00 a.m. et to provide a corporate update and review the company's results for the year ended december 31, 2023. listeners can register for the webcast via this link. analys.
MNMD Ratings Summary
MNMD Quant Ranking